Dna X (SONM) Gross Margin (2018 - 2025)

Dna X has reported Gross Margin for 8 years, with the latest figure at 11.2% in Q3 2025.

• For the quarter ending Q3 2025, Gross Margin fell 1697.0% year-over-year to 11.2%; the trailing twelve-month figure through Sep 2025 stood at 18.33% (down 850.0% YoY), and the FY2024 full-year result was 17.02%, down 362.0% from the prior year.
• Gross Margin for Q3 2025 stood at 11.2%, up from 7.55% in the prior quarter.
• The five-year high for Gross Margin was 49.97% in Q1 2025, with the low at 3.06% in Q4 2021.
• Historically, Gross Margin has averaged 18.39% across 5 years, with a median of 16.49% in 2023.
• Annual changes were most pronounced in 2024 — Gross Margin slumped 3934 bps — and 2025, when it soared 3267 bps.
• Dna X's Gross Margin stood at 3.06% in 2021, then surged by 633 bps to 16.3% in 2022, then jumped by 134 bps to 38.12% in 2023, then sank by 103 bps to 1.22% in 2024, then surged by 1017 bps to 11.2% in 2025.
• The last three Gross Margin figures came in at 11.2% (Q3 2025), 7.55% (Q2 2025), and 49.97% (Q1 2025), per Business Quant data.